COMMUNIQUÉS West-GlobeNewswire

Aleafia Secures First Cannabis Revenue in Sale to CannTrust
10/09/2018
Record Clinic Revenue in Q2 Along With Cannabis Sales to Provide Multiple Immediate Income Streams TORONTO, Sept. 10, 2018 (GLOBE NEWSWIRE) -- Aleafia Health Inc. (TSXV: ALEF; OTCQX: ALEAF) (“Aleafia“) or (the “Company [...]
A new chance for a smoke-free life - Acetium® lozenges available across Finland
10/09/2018
Free of nicotine and side effects, Acetium offers a totally new option for those seeking to quit smoking. Its effectiveness as a help for quitting smoking has been known for some years, and the link was confirmed in an [...]
Emblem announces proposed investment in Compass Cannabis Clinic, owner of Starbuds Canada
10/09/2018
TORONTO, Sept. 10, 2018 (GLOBE NEWSWIRE) -- Emblem Corp. (TSXV: EMC, OTCQX: EMMBF) (“Emblem” or the “Company”), today announced its intention to purchase approximately $1 million of units (“ Units ”) of 10330698 Canada [...]
Digirad Corporation Announces Conversion to Holding Company Structure
10/09/2018
Will Acquire ATRM Holdings as an Initial “Kick-off” Transaction Immediately Hires David Noble as COO SUWANEE, Ga., Sept. 10, 2018 (GLOBE NEWSWIRE) -- Digirad Corporation (NASDAQ: DRAD) (“Digirad” or “DRAD”) announced [...]
Achillion Appoints Paul Firuta Chief Operating Officer
10/09/2018
NEW HAVEN, Conn., Sept. 10, 2018 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN) today announced the appointment of Paul Firuta to the position of Executive Vice President and Chief Operating Officer [...]
Arrayit Corporation Approved for Direct Medicare Billing by the Centers for Medicare and Medicaid Services
10/09/2018
Sunnyvale, Sept. 10, 2018 (GLOBE NEWSWIRE) -- September 10, 2018 - Sunnyvale, CA – Arrayit Corporation (OTC: ARYC ), a life sciences and personalized medicine company, announces that Arrayit’s proprietary finger stick [...]
Sorrento Therapeutics Subsidiary, Scilex, Raises $140 million in Non-Dilutive Royalty-Based Financing to Support the Commercialization of Non-Opioid ZTlido™ Pain Medication
10/09/2018
Scilex plans to launch ZTlido™ (lidocaine topical system) 1.8% in October 2018 SAN DIEGO, Sept. 10, 2018 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (NASDAQ: SRNE) (“Sorrento”) announced today that its majority- [...]
Johanna Ivaska has been appointed Head & Vice President of Oncology Research in Orion Corporation
10/09/2018
ORION CORPORATION PRESS RELEASE 10 SEPTEMBER 2018 Johanna Ivaska has been appointed Head & Vice President of Oncology Research in Orion Corporation Johanna Ivaska (born 1972), Academy Professor of Biochemistry has [...]
Solon Eiendom ASA - Primary insider notification
10/09/2018
(Oslo, Norway, September 07, 2018) Solon Eiendom ASA Chairman of the Board Simen Thorsen has today through his wholly owned company Hortulan AS acquired 5,650 shares in Solon Eiendom ASA at a price of NOK 29.0211 per [...]
Xbrane Biopharma announces product portfolio update with a new full strategic focus on biosimilars
10/09/2018
Press release 2018-09-10 The board of directors of Xbrane Biopharma (publ.) ("Xbrane" or the Company) has decided to shift strategic focus in the Company's product pipeline to biosimilars. As Xbranes leading biosimilar [...]
A new big discovery from the Bio-on laboratories: also from the used cooking oil comes the bioplastic
10/09/2018
Waste oil is added to the "raw materials" already used to produce Bio-on bioplastic: beet molasses and sugar cane, fruit and potato wastes, carbohydrates in general and crude glycerol. A new discovery that transforms a [...]
Shire plc: Elections for the interim dividend in respect of the six months to June 30, 2018
10/09/2018
Elections for the interim dividend in respect of the six months to June 30, 2018 September 10, 2018 - Shire plc (LSE: SHP, NASDAQ: SHPG) (the “Company”) announced on July 31, 2018, an interim dividend of 5.60 US cents [...]
Oxurion NV Announces New NYSE Euronext Brussels Stock Ticker "OXUR" and Launch of New Websit
10/09/2018
Oxurion NV trading under "OXUR" on NYSE Euronext Brussels Oxurion NV launches new global website showcasing its comprehensive drug development approach and diverse portfolio of next-generation therapies for back of the [...]
Sensorion to Partner with Vestibular Disorders Association (VeDA) in Sponsorship of Balance Awareness Week 2018 for Vestibular Disorders
10/09/2018
MONTPELLIER, France, Sept. 10, 2018 (GLOBE NEWSWIRE) -- Sensorion ( FR 0012596468 – ALSEN ), a biotech company specializing in the treatment of inner ear diseases, today announces that it has joined with the Vestibular [...]
Innate Pharma announces data presentations at upcoming scientific meetings
10/09/2018
Innate Pharma announces data presentations at upcoming scientific meetings Updated long term follow-up data and new data from cohort expansion in the Phase I of IPH4102 in advanced CTCL at the EORTC CLTF 2018 Meeting [...]
Innate Pharma annonce la présentation de données lors de prochains congrès scientifiques
10/09/2018
INNATE PHARMA ANNONCE LA PRÉSENTATION DE DONNÉES LORS DE PROCHAINS CONGRÈS SCIENTIFIQUES Données de suivi à long terme et premières données de l'extension de cohorte pour la Phase I d'IPH4102 dans les lymphomes T [...]
NeuroSearch A/S receives notice of payment from Teva Pharmaceutical International GmbH regarding Pridopidine and changes financial outlook for 2018
08/09/2018
Company Announcement 8 September 2018 On 16 May 2018, NeuroSearch A/S ("NeuroSearch") entered into an agreement with, among others, Teva Pharmaceutical International GmbH ("Teva") (the "Agreement") to release Teva from [...]
Golden Leaf Holdings Refiles Amended and Restated MD&A
07/09/2018
TORONTO, Sept. 07, 2018 (GLOBE NEWSWIRE) -- Golden Leaf Holdings Ltd. (“GLH” or the “Company”) (CSE:GLH) (OTCQB:GLDFF), a cannabis company with cultivation, production and retail operations built around recognized [...]
Kalytera Announces Next Payment of Invoices in Shares under Payments Agreements with Salzman Group
07/09/2018
SAN FRANCISCO and TEL AVIV, Israel, Sept. 07, 2018 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (TSX VENTURE: KALY and OTCQB: KALTF) (the " Company " or " Kalytera ") today announced that the Company has elected to [...]

Pages